Showing results (541-550 of 1,351) with videos related to

Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|March 22, 2019
Pharmacokinetic Properties of Ibuprofen (IBU) From the Fixed-Dose Combination IBU/Caffeine (400/100 mg; FDC) in Comparison With 400 mg IBU as Acid or Lysinate Under Fasted and Fed Conditions-Data From 2 Single-Center, Single-Dose, Randomized Crossover Studies in Healthy VolunteersThomas Weiser, Cornelia Schepers, Tobias Mück, et al.
Clinical Pharmacology in Drug Development|March 7, 2017
Drug-Drug Interactions and Diagnostics for Drug Users With HIV and HIV/HCV Coinfections: IntroductionJag H Khalsa, Andrew H Talal, Gene Morse
Clinical Pharmacology in Drug Development|March 7, 2017
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir: Drug Interactions With Antiretroviral Agents and Drugs forSubstance AbuseJennifer R King, Rajeev M Menon
Clinical Pharmacology in Drug Development|March 7, 2017
Intrahepatic Sampling for the Elucidation of Antiviral Clinical PharmacologyCharles S Venuto, Andrew H Talal
Clinical Pharmacology in Drug Development|March 7, 2017
Asunaprevir: An HCV Protease Inhibitor With Preferential Liver DistributionTimothy Eley, Tushar Garimella, Wenying Li, et al.
Clinical Pharmacology in Drug Development|March 7, 2017
Drug- and Drug Abuse-Associated Hyperbilirubinemia: Experience With AtazanavirJayanta Roy-Chowdhury, Namita Roy-Chowdhury, Irving Listowsky, et al.
Clinical Pharmacology in Drug Development|March 7, 2017
Assessment of Hepatic Impairment and Implications for Pharmacokinetics of Substance Use TreatmentAndrew H Talal, Charles S Venuto, Islam Younis
Clinical Pharmacology in Drug Development|March 22, 2021
Evaluation of Drug-Drug Interaction Liability for Buprenorphine Extended-Release Monthly Injection Administered by Subcutaneous RouteJahnavi Kharidia, Eleanor M Howgate, Celine M Laffont, et al.
Clinical Pharmacology in Drug Development|November 16, 2021
Phase 1 Maximal Use Pharmacokinetic Study of Tirbanibulin Ointment 1% in Subjects With Actinic KeratosisRegina Yavel, J Scott Overcash, David Cutler, et al.
Clinical Pharmacology in Drug Development|July 26, 2022
A Phase 1 Thorough QT/QTc Study of Therapeutic and Supratherapeutic Doses of Belumosudil in Healthy SubjectsOlivier Schueller, Lauren Lohmer, Hongqi Xue, et al.
Pageof 136